OptimizeRx Corp
OPRX - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$138.26M
Close$
$6.00
18.2% downside
Current Fair Value
18.2% downsideOvervalued by 18.2% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $138.26 Million |
|---|---|
| Enterprise Value | $129.58 Million |
| Earnings per Share | $0.28 |
| Beta | 1.2 |
| Outstanding Shares | 18,866,127 |
Return
| Return on Equity | 3.75% |
|---|---|
| Return on Assets | 3.10% |
| Return on Invested Capital | 2.97% |
Valuation & Multiples
| P/E Ratio | 27.5 |
|---|---|
| PEG | 51.5 |
| Price to Sales | 1.84 |
| Price to Book Ratio | 1.05 |
| Enterprise Value to Revenue | 1.38 |
| Enterprise Value to EBIT | 28.81 |
| Enterprise Value to Net Income | 25 |
| Total Debt to Enterprise | 0.11 |
| Debt to Equity | 0.1 |
Revenue Sources
No data
Last Earnings Call
Report Date
November 11, 2026
EPS
$0.20
Est. $0.16Revenue
$21.61 M
Est. $21.19 MNext Earnings Call
Expected Date
March 4, 2027
EPS Estimate
$0.34
Consensus analyst estimateRevenue Estimate
$28.49 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.0000▼ 114.10% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 4.22%▼ 55.53% |
|---|---|
| Total Invested | $6.61M▼ 89.70% |
| Investors Holding | 27▼ 90.00% |
About OptimizeRx Corp
OptimizeRx is a digital health company that provides communications solutions for life science companies, physicians and patients. Connecting over half of healthcare providers in the U.S. and millions of patients through a proprietary ne...